AXS Investments’s Novo Nordisk NVO Stock Holding History

AXS Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$221K	Hold	6,000	–	–	0.09%	116
2025 Q4	$305K	Hold	6,000	–	–	0.11%	118
2025 Q3	$333K	Hold	6,000	–	–	0.1%	111
2025 Q2	$414K	Hold	6,000	–	–	0.17%	119
2025 Q1	$417K	Hold	6,000	–	–	0.12%	186
2024 Q4	$516K	Hold	6,000	–	–	0.14%	188
2024 Q3	$714K	Hold	6,000	–	–	0.19%	185
2024 Q2	$856K	Sell	6,000 -6,000	-50%	-$795K	0.24%	174
2024 Q1	$1.54M	Buy	12,000 +1,800	+18%	+$214K	0.37%	85
2023 Q4	$1.06M	Buy	+10,200	New	+$1.01M	0.25%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

AXS Investments's NVO Position: Q1 2026 in Review

AXS Investments held its Novo Nordisk (NVO) position steady in Q1 2026 at 6,000 shares worth $221K. The position accounts for 0.09% of the portfolio, ranked #116.

AXS Investments first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.54M in Q1 2024. 1,270 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

AXS Investments held 6,000 shares of Novo Nordisk worth $221K as of Q1 2026.
AXS Investments left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up 0.09% of AXS Investments's portfolio in Q1 2026, its #116 holding.
AXS Investments first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
AXS Investments's Novo Nordisk position peaked at $1.54M in Q1 2024.
1,270 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.